These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24313654)

  • 1. Origin of Langerhans cells in normal skin and chronic GVHD after hematopoietic stem-cell transplantation.
    Andani R; Robertson I; Macdonald KP; Durrant S; Hill GR; Khosrotehrani K
    Exp Dermatol; 2014 Jan; 23(1):75-7. PubMed ID: 24313654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent detection of herpes simplex virus antigen in skin and peripheral blood CD34+ mononuclear cells from patients with graft-versus-host disease.
    Akpek G; Joseph R; Günay C; Kessler II; Shvartsbeyn M; Bhatnagar B; Aurelian L
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):529-37. PubMed ID: 23313704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Langerhans cell homeostasis and turnover after nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation.
    Mielcarek M; Kirkorian AY; Hackman RC; Price J; Storer BE; Wood BL; Leboeuf M; Bogunovic M; Storb R; Inamoto Y; Flowers ME; Martin PJ; Collin M; Merad M
    Transplantation; 2014 Sep; 98(5):563-8. PubMed ID: 24717220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.
    Fraile P; Vazquez L; Caballero D; Garcia-Cosmes P; López L; San Miguel J; Tabernero JM
    Eur J Haematol; 2013 Aug; 91(2):129-34. PubMed ID: 23710658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia.
    Sánchez-García J; Serrano J; Gómez P; Martínez F; Martín C; Román-Gómez J; Rodríguez A; Herrera C; García JM; Alvarez MA; Torres A
    Haematologica; 2006 Mar; 91(3):340-7. PubMed ID: 16531257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between the kinetics of CD3+ chimerism and the incidence of graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Rupa-Matysek J; Lewandowski K; Nowak W; Sawiński K; Gil L; Komarnicki M
    Transplant Proc; 2011 Jun; 43(5):1915-23. PubMed ID: 21693300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of Langerhans' cells in oral chronic graft-vs.-host disease.
    Orti-Raduan ES; Nunes AJ; Oliveira DT; Lara VS; Taveira LA
    J Oral Pathol Med; 2009 Jan; 38(1):132-7. PubMed ID: 19054287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early-onset lichenoid graft-vs.-host disease: a unique variant of acute graft-vs.-host disease occurring in peripheral blood stem cell transplant recipients.
    Magro CM; Kerns MJ; Votava H; Vasil KE; Dyrsen ME; Morrison CD
    J Cutan Pathol; 2010 May; 37(5):549-58. PubMed ID: 19843195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A question of persistence: Langerhans cells and graft-versus-host disease.
    Collin M; Jardine L
    Exp Dermatol; 2014 Apr; 23(4):234-5. PubMed ID: 24443966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genital chronic GVHD in men after hematopoietic stem cell transplantation: a single-center cross-sectional analysis of 155 patients.
    Mueller SM; Haeusermann P; Rovó A; Halter JP; Passweg J; Itin P; Tichelli A
    Biol Blood Marrow Transplant; 2013 Nov; 19(11):1574-80. PubMed ID: 23962394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation?
    Hirshfeld E; Weiss L; Kasir J; Zeira M; Slavin S; Shapira MY
    Bone Marrow Transplant; 2006 Sep; 38(5):359-64. PubMed ID: 16862165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjunctival polyploid cells and donor-derived myofibroblasts in ocular GvHD.
    Hallberg D; Stenberg K; Hanson C; Stenevi U; Brune M
    Bone Marrow Transplant; 2016 May; 51(5):692-7. PubMed ID: 26808567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation.
    El-Cheikh J; Vazquez A; Crocchiolo R; Furst S; Calmels B; Castagna L; Lemarie C; Granata A; Ladaique P; Oudin C; Faucher C; Chabannon C; Blaise D
    Am J Hematol; 2012 Dec; 87(12):1074-8. PubMed ID: 22911907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
    Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of graft-versus-host disease on skin endothelial and epithelial cell chimerism in stem-cell transplant recipients.
    Willemze AJ; Bakker AC; von dem Borne PA; Bajema IM; Vossen JM
    Transplantation; 2009 Apr; 87(7):1096-101. PubMed ID: 19352133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
    Lo JW; Leung AY; Huang XR; Lie AK; Metz C; Bucala R; Liang R; Lan HY
    Bone Marrow Transplant; 2002 Sep; 30(6):375-80. PubMed ID: 12235522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular graft-versus-host disease after allogeneic stem cell transplantation.
    Westeneng AC; Hettinga Y; Lokhorst H; Verdonck L; van Dorp S; Rothova A
    Cornea; 2010 Jul; 29(7):758-63. PubMed ID: 20489577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
    Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
    Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial reconstitution of cutaneous microvessels in long-term survivors after allogeneic bone marrow transplantation.
    Haeusermann P; Kump E; Rovó A; Tichelli A; Itin P; Gratwohl A; Biedermann BC
    Dermatology; 2009; 219(1):32-41. PubMed ID: 19407437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.